Market Size of Disposable Incontinence Products (DIPs) Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | Asia-Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Disposable Incontinence Products (DIPs) Market Analysis
The disposable incontinence products (DIPs) market is expected to witness a CAGR of 5.0% during the forecast period.
Renal failure is the prevailing cause of death from COVID-19. Together with other parameters that constitute the risk profile for severe COVID-19 evolution, disposable incontinence products proved extremely useful for the elderly patient management of COVID-19. According to a Johns Hopkins University article on the impact of COVID-19 on kidney diseases updated in March 2022, some people infected with COVID-19 showed signs of kidney damage, and even those with no prior kidney problems were infected. Furthermore, approximately 30% of COVID-19 patients hospitalized in New York and China developed moderate or severe kidney injury. Moreover, the increasing number of hospitalizations during the COVID-19 pandemic also contributed to the augmented demand for disposable incontinence products. Thus, COVID-19 had a profound impact on the market studied.
The key factors propelling the growth of the market studied are the rising prevalence of renal diseases and nephrological injuries, technological advancements in the material used for disposable products and catheters, and increasing awareness about personalized care and hygiene. For instance, according to an article published in Elsevier in October 2021, the prevalence of UI ranged from 20.3% to 54.5%. Stress UI was the main type reported. The main predisposing factors were chronic respiratory diseases and constipation. Thus, rising prevalence of diseases are expected to boost the market during the forecast period.
New product launches are expected to fuel the market during the forecast period. For instance, in November 2021, the Flume Catheter Company Ltd (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced that it received clearance from the US Food and Drug Administration (FDA) to market the Flume catheter in the United States. Thus, the market strategies opted by suppliers and manufactures will contribute toward the growth of market.
However, severity of side effects associated with the continuous use of incontinence products and limited reimbursement are expected to restrain thegrowth of the market during the forecast period.
